These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27094128)

  • 1. Live cell imaging shows hepatocyte growth factor-induced Met dimerization.
    Koschut D; Richert L; Pace G; Niemann HH; Mély Y; Orian-Rousseau V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1552-8. PubMed ID: 27094128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
    Niemann HH
    Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the structure address on MET receptor activation by HGF.
    Linossi EM; Estevam GO; Oshima M; Fraser JS; Collisson EA; Jura N
    Biochem Soc Trans; 2021 Apr; 49(2):645-661. PubMed ID: 33860789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimerization of the Trk receptors in the plasma membrane: effects of their cognate ligands.
    Ahmed F; Hristova K
    Biochem J; 2018 Nov; 475(22):3669-3685. PubMed ID: 30366959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
    Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
    Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of EGF receptor oligomerization by homo-FRET.
    de Heus C; Kagie N; Heukers R; van Bergen en Henegouwen PM; Gerritsen HC
    Methods Cell Biol; 2013; 117():305-21. PubMed ID: 24143984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining protein complementation assays with resonance energy transfer to detect multipartner protein complexes in living cells.
    Rebois RV; Robitaille M; Pétrin D; Zylbergold P; Trieu P; Hébert TE
    Methods; 2008 Jul; 45(3):214-8. PubMed ID: 18586102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
    Li Y; Fan X; Goodwin CR; Laterra J; Xia S
    BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B.
    Tannoo RM; Richert L; Koschut D; Tomishige N; Treffert SM; Kobayashi T; Mély Y; Orian-Rousseau V
    Biochim Biophys Acta Biomembr; 2024 Jan; 1866(1):184236. PubMed ID: 37793560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the activation of c-MET receptor.
    Uchikawa E; Chen Z; Xiao GY; Zhang X; Bai XC
    Nat Commun; 2021 Jul; 12(1):4074. PubMed ID: 34210960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
    Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
    Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
    Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2.
    Tacchini L; Dansi P; Matteucci E; Desiderio MA
    Exp Cell Res; 2000 Apr; 256(1):272-81. PubMed ID: 10739674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into Met receptor activation.
    Niemann HH
    Eur J Cell Biol; 2011 Nov; 90(11):972-81. PubMed ID: 21242015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
    Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP
    Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial human Met agonists based on macrocycle scaffolds.
    Ito K; Sakai K; Suzuki Y; Ozawa N; Hatta T; Natsume T; Matsumoto K; Suga H
    Nat Commun; 2015 Mar; 6():6373. PubMed ID: 25758345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem/progenitor cell motility.
    Fang JD; Lee SL
    Biochim Biophys Acta; 2014 Jul; 1843(7):1285-94. PubMed ID: 24685580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.